Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis
Atherosclerosis, the leading cause of death worldwide, is a chronic inflammatory disease leading to the accumulation of lipid-rich plaques in the intima of large and medium-sized arteries. Accumulating evidence indicates the important regulatory role of the adaptive immune system in atherosclerosis...
Saved in:
Main Authors: | Despina Giakomidi, Ayoola Ishola, Meritxell Nus |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1502124/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dietary secoisolariciresinol diglucoside ameliorates high-fat diet-induced atherosclerosis via regulating immunological inflammation and reshaping gut microbiota in ApoE-/- mice
by: Yiwei Li, et al.
Published: (2025-01-01) -
Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic
by: Fengge Wang, et al.
Published: (2025-01-01) -
Crosstalk between Gut Microbiota Metabolites and Ischemic Stroke
by: TANG Qiang
Published: (2022-10-01) -
Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis
by: Xiaohui Leng, et al.
Published: (2025-01-01) -
In vitro gastrointestinal digestion and colonic fermentation of Mangiferin: Impacts on gut microbiota and metabolite profiles
by: Huilin Deng, et al.
Published: (2025-01-01)